Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2005
12/22/2005WO2005102366A3 Lithium combinations, and uses related thereto
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005089779A3 Rapidly disintegrating taste-masked tablet
12/22/2005WO2005063697A3 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
12/22/2005WO2005051321A3 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase
12/22/2005WO2005023233A3 Antimicrobial compositions and methods
12/22/2005WO2005000216A8 Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
12/22/2005WO2004078117A3 Method for increasing hair growth
12/22/2005WO2004062580A3 Odorless formulation for treating mucosal discontinuities
12/22/2005WO2004060317A3 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282910 Methods of application of chemical compounds having therapeutic activities in treating cancers
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282902 Abnormal cannabidiols as agents for lowering intraocular pressure
12/22/2005US20050282896 Methods of cardioprotection using dichloroacetate in combination with an inotrope
12/22/2005US20050282892 Pharmaceutical composition useful for treating chronic myeloid leukemia
12/22/2005US20050282873 Epothilone derivative for the treatment of hepatoma and other cancer diseases
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282859 Dual acting SNRI-NMDA antagonists for the treatment of genitourinary disorders
12/22/2005US20050282830 Use of dipyridamole or mopidamole for treatment and prevention of MMP-9-dependent disorders
12/22/2005US20050282799 Method of treating lower urinary tract disorders
12/22/2005US20050282794 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
12/22/2005US20050282771 treating bleeding disorder selected from a chronic or acute bleeding disorder, a congenital coagulation disorder caused by a blood factor deficiency, and an acquired coagulation disorder, by administering a composition comprising a procoagulant amount of a fucoidan
12/22/2005US20050282769 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
12/22/2005US20050282758 6-11 Bicyclic ketolide derivatives
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282277 Methods of increasing platelet and hematopoietic stem cell production
12/22/2005US20050282272 inducing a reduced lymphocyte proliferative response to a Major Histocomatibilty Complex (MHC) type presented on an human embryonic stem (hES) cell in a subject; induces a state of inflammatory quiescence or immune unresponsiveness, which in turn enhances engraftment of the stem cells
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282205 GLUT5 transporters expressed in cancer cells
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281903 Extract of Stephaniae sinica Diels and methods of using the same
12/22/2005US20050281895 Slimming cosmetic composition containing a substance inducing the production of IL-6
12/22/2005US20050281889 Nutritional supplement for adults
12/22/2005US20050281888 Nutritional supplement for infants
12/22/2005US20050281875 Promethazine containing dosage form
12/22/2005US20050281846 Local administration of a botulinum toxin, especially botulinum toxin type A, to an injured muscle to facilitate healing of injured biceps, knee or shin muscles.
12/22/2005US20050281832 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281821 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281797 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd
12/22/2005US20050281796 Targeting damaged lung tissue
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281789 Transcutaneous and/or transdermal transport of materials
12/22/2005US20050281788 Compositions comprising muscle progenitor cells and uses thereof
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005DE102004027685A1 Method and composition useful e.g. to improve the symptoms of hypersensitive teeth or toothache comprises applying topical formulation comprising sodium-channel blockers (e.g. tetracaine or bupivacaine) and additives on the tooth surface
12/22/2005DE102004025601A1 Vitaminization of materials, e.g. bed, comprises impregnation of vitamins during the fabrication of the materials, where the vitamins are repeatedly added during the use and added along with prefabricated solutions and powders
12/22/2005CA2569738A1 Dispenser for progestin used for acute and maintenance treatment of dub
12/22/2005CA2569590A1 Drug having regulatory cell ligand contained in liposome
12/22/2005CA2569411A1 Methods and compositions for treating mood disorder
12/22/2005CA2569072A1 Preparation for localized delivery of therapeutic agent
12/22/2005CA2568929A1 Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
12/22/2005CA2568305A1 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2565262A1 Nutritional formulations
12/22/2005CA2565102A1 Novel use of peptide compounds for treating amyotrophic lateral sclerosis
12/22/2005CA2565101A1 Novel use of peptide compounds for treating pain in trigeminal neuralgia
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607103A1 Concomitant drug as therapeutic agent for inflammatory bowel disease
12/21/2005EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein
12/21/2005EP1607088A1 Controlled release composition
12/21/2005EP1606285A1 Novel ido inhibitors and methods of use
12/21/2005EP1605996A2 Medical devices with enhanced ultrasonic visibility
12/21/2005EP1605976A1 PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA
12/21/2005EP1605967A1 Novel nph insulin preparations
12/21/2005EP1605956A1 Administration of capsaicinoids
12/21/2005EP1605954A1 A food-supplement composition suitable for promoting iron absorption
12/21/2005EP1605951A1 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
12/21/2005EP1605950A2 Novel chemical entities and methods for their use in treatment of metabolic disorders
12/21/2005EP1605949A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
12/21/2005EP1605935A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
12/21/2005EP1605924A2 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
12/21/2005EP1605921A1 Formulations comprising an active ingredient and cocoa powder and use thereof
12/21/2005EP1605920A1 Formulations comprising tolterodine and cocoa powder and use thereof
12/21/2005EP1605895A2 Oral insulin therapies and protocol
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1286674A4 Methods and compositions for potentiating cancer chemotherapeutic agents
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP1066038B1 Use of cabergoline in the treatment of restless legs syndrome
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005CN1711107A Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker
12/21/2005CN1711095A Composition for restoring damaged skin
12/21/2005CN1711094A Combination product of inhibitor of the SRC family of non-receptor tyrosine kinases and gemcitabine
12/21/2005CN1711091A The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 1151